DAJY(SZ:002030) Shang Hai Zheng Quan Bao·2025-09-26 19:57Core Points - The company has obtained a medical device registration certificate for a Chikungunya virus nucleic acid detection kit, which is intended for in vitro qualitative detection of the virus in suspected cases [1][2] - The registration certificate is valid until September 24, 2030, and the product is currently in the market development stage, indicating potential uncertainty in market demand [2][3] Group 1 - The medical device name is Chikungunya Virus Nucleic Acid Detection Kit (Fluorescent PCR Method), with registration number 20253401955 [1] - The kit is designed for detecting Chikungunya virus nucleic acid in serum samples from suspected cases and should be used in accordance with relevant guidelines [1][2] - The company emphasizes that the test results are for clinical reference only and should not be the sole basis for clinical diagnosis [1] Group 2 - The acquisition of this registration certificate enriches the company's product portfolio and expands its application areas [2] - The company advises investors to be aware of investment risks due to the current uncertainty in market demand for the new product [2]